loratadine has been researched along with Cancer of Pancreas in 2 studies
Loratadine: A second-generation histamine H1 receptor antagonist used in the treatment of allergic rhinitis and urticaria. Unlike most classical antihistamines (HISTAMINE H1 ANTAGONISTS) it lacks central nervous system depressing effects such as drowsiness.
loratadine : A benzocycloheptapyridine that is 6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine substituted by a chloro group at position 8 and a 1-(ethoxycarbonyl)piperidin-4-ylidene group at position 11. It is a H1-receptor antagonist commonly employed in the treatment of allergic disorders.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Desai, P | 2 |
| Wang, KZ | 1 |
| Ann, D | 2 |
| Wang, J | 2 |
| Prabhu, S | 2 |
| Thakkar, A | 1 |
2 other studies available for loratadine and Cancer of Pancreas
| Article | Year |
|---|---|
Efficacy and Pharmacokinetic Considerations of Loratadine Nanoformulations and its Combinations for Pancreatic Cancer Chemoprevention.
Topics: Administration, Oral; Animals; Biological Availability; Cell Line, Tumor; Cell Survival; Chemopreven | 2020 |
Loratadine self-microemulsifying drug delivery systems (SMEDDS) in combination with sulforaphane for the synergistic chemoprevention of pancreatic cancer.
Topics: Anticarcinogenic Agents; Cell Line, Tumor; Cell Survival; Chemoprevention; Drug Delivery Systems; Dr | 2019 |